Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
118.77
-0.18 (-0.15%)
Official Closing Price
Updated: 5:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
40
41
Next >
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
January 26, 2023
There's more to the story than the negative trends for Abbott's top and bottom lines.
Via
The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
January 26, 2023
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Why Abbott Laboratories Stock Got Whacked on Wednesday
January 25, 2023
Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day.
Via
The Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
January 25, 2023
ABT earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
January 25, 2023
Via
Benzinga
What's Going On With Abbott Laboratories Stock Today?
January 25, 2023
Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday in the wake of the company's quarterly results.
Via
Benzinga
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
January 25, 2023
Overall sales topped forecasts, but organic growth missed expectations.
Via
Investor's Business Daily
A Bullish Sign Appears On Abbott Laboratories's Chart
January 24, 2023
Via
Benzinga
Earnings Outlook For Abbott Laboratories
January 24, 2023
Via
Benzinga
FDA Approves Abbott's Next-Gen Navitor TAVI System For Aortic Stenosis
January 17, 2023
Via
Benzinga
Why Aurora Cannabis Stock Is Fading Today
January 25, 2023
With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.
Via
The Motley Fool
Abbott Q4 Earnings And Revenues Top Estimates
January 25, 2023
Abbott came out with quarterly earnings of $1.03 per share.
Via
Talk Markets
Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower
January 25, 2023
(Wednesday Market Open) The market gives and the market takes away.
Via
Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
January 25, 2023
U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading:
Via
Benzinga
Earnings Scheduled For January 25, 2023
January 25, 2023
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion.
Via
Benzinga
Investor Optimism Declines Following Earnings Reports
January 25, 2023
The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings.
Via
Benzinga
Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades'
January 24, 2023
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Viper Energy Partners LP (NASDAQ: VNOM), which is a subsid
Via
Benzinga
Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk
January 23, 2023
(Monday Market Open) This week and next could go a long way toward determining how the current quarter plays out on Wall Street.
Via
Benzinga
Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories
January 23, 2023
Reuters Juul's Consumer Settlement Is 'Reasonable & Adequate,' US Judge Says
Via
Benzinga
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023
January 23, 2023
It doesn't get any safer for income investors than Dividend Kings.
Via
The Motley Fool
6 Dividend Growth Stocks
January 22, 2023
Interested in knowing about companies that are paying their shareholders even bigger dividends than before? Today I want to tell you about six dividend growth stocks that just increased their...
Via
Talk Markets
Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space?
January 22, 2023
Netflix, Inc. (NASDAQ: NFLX) shares jumped nearly 8.5% on Friday before settling at their highest level since April 19, 2022, when shares plunged after the company reported its first loss in net paid...
Via
Benzinga
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
January 21, 2023
The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT).
Via
Benzinga
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 19, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
3 Top Passive-Income Stocks to Own in 2023
January 19, 2023
These stocks can add safety and growth to your portfolio.
Via
The Motley Fool
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via
MarketBeat
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via
Talk Markets
Zoetis, SL Green Realty, Abbott Laboratories And This Big Bank Reporting Earnings On Friday: CNBC's 'Final Trades'
January 12, 2023
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc.
Via
Benzinga
Should You Buy This Promising New Healthcare Stock?
January 12, 2023
Shares of GE Healthcare began trading last week after the company completed its spinoff from General Electric.
Via
The Motley Fool
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
January 11, 2023
These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.
Via
The Motley Fool
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.